Aqr Capital Management LLC Novo Cure LTD Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Aqr Capital Management LLC holds 16,514 shares of NVCR stock, worth $496,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,514

Previous 431,445 96.17%

Holding current value

$496,741

Previous $7.39 Million 96.51%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.61 - $23.34 $6.48 Million - $9.68 Million	-414,931 Reduced 96.17%	16,514 $258,000
Q2 2024 Aug 14, 2024	BUY	$11.83 - $24.05 $3.58 Million - $7.27 Million	302,351 Added 234.21%	431,445 $7.39 Million
Q1 2024 May 15, 2024	SELL	$12.42 - $17.29 $388,087 - $540,260	-31,247 Reduced 19.49%	129,094 $2.02 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $1.46 Million - $2.06 Million	130,794 Added 442.66%	160,341 $2.39 Million
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $477,184 - $1.25 Million	29,547 New	29,547 $477,000
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $353,401 - $574,206	-4,707 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $1.51 Million - $2.52 Million	-12,973 Reduced 73.38%	4,707 $546,000
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $869,637 - $1.5 Million	-6,669 Reduced 27.39%	17,680 $3.92 Million
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $1.69 Million - $2.59 Million	13,622 Added 126.99%	24,349 $3.18 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $1.2 Million - $1.87 Million	10,727 New	10,727 $1.86 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $4.76 Million - $9.13 Million	-82,003 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$57.2 - $74.41 $472,014 - $614,031	8,252 Added 11.19%	82,003 $4.86 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $2.04 Million - $3.42 Million	35,686 Added 93.75%	73,751 $4.97 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $141,585 - $194,447	-2,073 Reduced 5.16%	38,065 $3.21 Million
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $509,664 - $805,774	8,239 Added 25.83%	40,138 $3 Million
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $281,100 - $420,985	-6,658 Reduced 17.27%	31,899 $2.02 Million
Q1 2019 May 14, 2019	SELL	$31.96 - $56.12 $136,181 - $239,127	-4,261 Reduced 9.95%	38,557 $1.86 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $4.42 Million - $8.1 Million	-153,893 Reduced 78.23%	42,818 $1.43 Million
Q3 2018 Nov 15, 2018	SELL	$32.0 - $52.4 $1.04 Million - $1.7 Million	-32,399 Reduced 14.14%	196,711 $10.3 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $1.05 Million - $1.68 Million	52,649 Added 29.84%	229,110 $7.17 Million
Q1 2018 May 15, 2018	BUY	$19.3 - $23.65 $205,834 - $252,227	10,665 Added 6.43%	176,461 $3.85 Million
Q4 2017 Feb 14, 2018	BUY	$16.3 - $21.9 $2.29 Million - $3.07 Million	140,292 Added 550.08%	165,796 $3.35 Million
Q3 2017 Nov 14, 2017	BUY	$18.05 - $21.75 $460,347 - $554,712	25,504	25,504 $506,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.16B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Novo Cure LTD Transaction History